-
This prospective, randomized clinical trial attempted to determine if there was any difference in outcome between lacerations closed with traditional nonabsorbable sutures vs. those closed with fast-absorbing gut.
-
The pharmacologic profile of midazolam, a short-acting benzodiazepine, led the authors to hypothesize that this drug would compare favorably with lorazepam and haloperidol in the sedation of violent and severely agitated patients in the ED.
-
The glycoprotein IIb-IIIa receptor inhibitor agents represent a relatively recent addition to the therapeutic armamentarium employed in the treatment of the patient with acute coronary syndrome.
-
-
Prednisolone, a glucocorticoid that is sometimes added to antituberculosis drug regimens, should not be used to treat patients with pleural tuberculosis and HIV infection, nor can it be recommended for those with pleural tuberculosis who are not coinfected with HIV, according to a study in the Aug. 15 issue of The Journal of Infectious Diseases.
-
New indication for imiquimod (Aldara) topical cream by 3M Pharmaceuticals; NeutroSpec (formerly LeuTech) by Mallinckrodt and Palatin Technologies; Fixed-dose combination treatment of abacavir/lamivudine (Epzicom) and tenofovir disoproxil/emtricitabine (Truvada) by GlaxoSmithKline and Gilead Sciences, respectively.
-
Clinical Studies; Acute bacterial exacerbation of chronic bronchitis (AECB); Acute bacterial sinusitis (ABS); Community-acquired pneumonia (CAP); Adverse events; Drug interactions; Recommendations.
-
-
Are you collecting data elements concurrently, while patients still are receiving care, or retrospectively after discharge? Each approach has distinct advantages and disadvantages, and which is best depends on the individual situation, says Patrice L. Spath, a health care quality specialist with Forest Grove, OR-based Brown-Spath & Associates.
-
There are several key changes for the Joint Commission on Accreditation of Healthcare Organizations revised medical staff standards, which became effective as of January 2004. I see these as nothing less than revolutionary, says Martin D. Merry, MD, adjunct associate clinical professor of health management and policy at the University of New Hampshire in Durham.
